Impel presented four scientific abstracts as part of the 2022 American Academy of Neurology Annual Meeting, including data from our pivotal Phase 3 STOP-301 trial of Trudhesa® for the acute treatment of migraine.

Impel attended the 2022 Headache Cooperative of the Pacific’s 14th Annual Winter Conference, held January 28-29 to support communication among headache providers and researchers. This two-day, educational and informative event provides the necessary tools and best practices to better diagnose…

Impel presented two oral abstracts at the International Headache Society and the European Headache Federation joint virtual International Headache Congress, held September 8-12. The congress centered around the theme of “Headache science to optimize patient care.”